Detalhe da pesquisa
1.
The pericyte-glia interface at the blood-brain barrier.
Clin Sci (Lond);
132(3): 361-374, 2018 02 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29439117
2.
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.
Proc Natl Acad Sci U S A;
111(36): E3825-30, 2014 Sep 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25157130
3.
The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.
Neurobiol Dis;
86: 29-40, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26581638
4.
Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
Neurobiol Dis;
88: 107-17, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26774030
5.
Environmental bacteria as triggers to brain disease: Possible mechanisms of toxicity and associated human risk.
Life Sci;
304: 120689, 2022 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35679915
6.
Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats.
J Pharmacol Exp Ther;
332(1): 164-72, 2010 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19815811
7.
Peripheral Routes to Neurodegeneration: Passing Through the Blood-Brain Barrier.
Front Aging Neurosci;
12: 3, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32116645
8.
Donecopride, a Swiss army knife with potential against Alzheimer's disease.
Br J Pharmacol;
177(9): 1988-2005, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31881553
9.
Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.
Eur J Neurosci;
29(12): 2363-74, 2009 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19490084
10.
Editorial: Environmental clues to brain disease.
Front Aging Neurosci;
15: 1220484, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37383358
11.
Histamine in the brain: beyond sleep and memory.
Biochem Pharmacol;
73(8): 1113-22, 2007 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17241615
12.
Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease.
Neuropharmacology;
126: 128-141, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28844596
13.
Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases.
J Vis Exp;
(118)2016 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28060355
14.
In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aß protein.
Front Aging Neurosci;
8: 223, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27729857
15.
Serotonin: A New Hope in Alzheimer's Disease?
ACS Chem Neurosci;
6(7): 940-3, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26011650
16.
Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's Disease.
Front Aging Neurosci;
12: 169, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32612524
17.
Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.
J Med Chem;
58(7): 3172-87, 2015 Apr 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25793650
18.
Serotonin type 4 receptor dimers.
Methods Cell Biol;
117: 123-39, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24143975
19.
Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease.
Front Aging Neurosci;
5: 96, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24399967
20.
Alzheimer culprits: cellular crossroads and interplay.
Cell Signal;
24(9): 1831-40, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22627093